India, a vaccine manufacturing hub, is in the thick of the action as the global pharma industry races to find a cure or vaccine for Covid-19. Serum Institute of India (SII) is one Indian manufacturer that is developing a vaccine and is hopeful of a successful partnership with researchers in Oxford University. But its optimism is guarded, given the uncertainties involved in the various stages of vaccine trials. The Pune-based company also plans to start trials on people to assess whether the Bacille Calmette-Guérin (BCG) vaccine for tuberculosis can also protect against the Covid-19 virus. It has also collaborated with
Wednesday, December 17, 2025 | 12:55 AM ISTहिंदी में पढें
Serum Institute hopes to roll out a Covid-19 vaccine. Is this realistic?
The Pune-based company plans to start trials on people to assess whether the Bacille Calmette-Guerin (BCG) vaccine for tuberculosis can also protect against the Covid-19 virus.
 "Serum institute, coronavirus, vaccine, pharma, drugs")
premium
The vaccine developed by an Oxford University group led by Andrew Hill, director of the Jenner Institute, has held out the most promise in the global race.
